Increased Risk of Relapse for ALL Patients Living in Extreme Poverty
Among children receiving maintenance therapy for ALL, those living in extreme poverty had a nearly 2-fold greater risk of relapse than those not living in extreme poverty.
Diagnosis & Disease Information
Overweight/Obese BMI Linked to Worse Survival in ALL Patients
For patients with acute lymphoblastic leukemia treated on pediatric regimens, overweight or obese BMI is associated with worse outcomes.
Sorafenib Maintenance After Transplant Deemed Standard Care for FLT3-ITD AML
Updated phase 3 data support sorafenib maintenance after allogeneic transplant as standard care for patients with FLT3-ITD AML, according to researchers.
Blincyto Granted Full Approval for MRD-Positive B-Cell Precursor ALL
Blincyto is supplied as a 35 mcg strength lyophilized powder for intravenous infusion after reconstitution.
ASCO 2023: Ground-Breaking Results With CAR T-Cell Therapies
Studies of CAR T-cell therapies presented at ASCO 2023 broke new ground and may change practice, according to researchers.
Ponatinib Plus Chemo May Be New Standard Care in Newly Diagnosed Ph+ ALL
A phase 3 trial suggests that ponatinib is more effective than imatinib for patients with newly diagnosed Ph+ acute lymphoblastic leukemia.
Obecabtagene Autoleucel Appears Safe, Effective in Relapsed/Refractory B-ALL
Obecabtagene autoleucel produced a high response rate in adults with relapsed/refractory B-ALL in a phase 2 study.
Adult Survivors of Childhood Cancer May Face Late-Onset Memory Impairment
Adult survivors of childhood cancer have an elevated risk of late-onset memory impairment, a study suggests.
Adding Blinatumomab to Chemotherapy May Improve Survival in Infant ALL
The combination of blinatumomab and chemotherapy appears safe and effective in infants with KMT2A-rearranged ALL, according to researchers.
Texas-Mexico Border Residence Linked to Worse Survival in Children With ALL
Living along the Texas-Mexico border is associated with worse survival in children diagnosed with acute lymphoblastic leukemia.
- Loading...
Loading...
Next post in Hematologic Cancers
Loading... 
Loading...